SELLAS Life Sciences Group, Inc. (SLS) Tops Q2 EPS by 5c
Tweet
Share
E-mailGet Alerts SLS Hot Sheet
Join SI Premium – FREE
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q2 EPS of ($0.31), $0.05 better than the analyst estimate of ($0.36).
For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
- ASML Holding NV (ASML:NA) (ASML) PT Raised to EUR2,000 at Goldman Sachs
- JPMorgan Reinstates Adidas AG (ADS:GR) (ADDYY) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
